Literature DB >> 11594947

Initial stages of posterior vitreous detachment in healthy eyes of older persons evaluated by optical coherence tomography.

E Uchino1, A Uemura, N Ohba.   

Abstract

OBJECTIVE: To promote understanding of the development of posterior vitreous detachment (PVD) in healthy eyes using optical coherence tomography (OCT).
METHODS: We studied 209 eyes of 209 healthy volunteers (165 men and 44 women; mean age, 52.3 years [range, 31-74 years]). In addition to biomicroscopy and ophthalmoscopy, OCT was performed to obtain high-resolution cross-sectional images of the vitreoretinal interface in the posterior fundus.
RESULTS: The condition of the posterior vitreoretinal interface was classified as 1 of 5 stages, according to biomicroscopic findings and OCT images relative to discrete linear signals indicating a detached posterior vitreous face: stage 0, no PVD (61 eyes [29.2%]); stage 1, incomplete perifoveal PVD in up to 3 quadrants (100 eyes [47.8%]); stage 2, incomplete perifoveal PVD in all quadrants, with residual attachment to the fovea and optic disc (26 eyes [12.4%]); stage 3, incomplete PVD over the posterior pole, with residual attachment to the optic disc (4 eyes [1.9%]); or stage 4, complete PVD identified with biomicroscopy, but not with OCT because of instrument limitations (18 eyes [8.6%]). Stage 1, 2, and 3 incomplete PVD without subjective symptoms was not recognizable on contact lens biomicroscopy. There was a significant age-related progression in the condition of the vitreoretinal interface from stage 0 to stage 4. The superior quadrant was usually the initial site of incomplete PVD.
CONCLUSIONS: Optical coherence tomography demonstrates that healthy human eyes have incomplete or partial PVD beginning as early as the fourth decade of life. Age-related PVD occurs initially as a focal detachment in the perifovea of 1 quadrant, with persistent attachment to the fovea and optic nerve head, with a predilection for the superior quadrant. It extends its range slowly for years and eventually results in complete PVD, associated with release of vitreopapillary adhesion.

Entities:  

Mesh:

Year:  2001        PMID: 11594947     DOI: 10.1001/archopht.119.10.1475

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  69 in total

1.  Vitreo-retinal interface changes on optical coherence tomography in the fellow eyes of patients with macular hole.

Authors:  Ajit Babu Majji; Jay Kumar Chhablani; Bupesh Bagga
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

2.  Optical coherence tomography of the vitreomacular interface in photodynamic therapy.

Authors:  A J Witkin; J S Duker
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

3.  Vitreofoveal attachment causing metamorphopsia: an ultrahigh-resolution optical coherence tomography finding.

Authors:  Andre J Witkin; Tony H Ko; James G Fujimoto; Joel S Schuman; Elias Reichel; Jay S Duker
Journal:  Retina       Date:  2006 Nov-Dec       Impact factor: 4.256

4.  Perifoveal vitreous detachment and its macular complications.

Authors:  Mark W Johnson
Journal:  Trans Am Ophthalmol Soc       Date:  2005

5.  Is axial length a risk factor for idiopathic macular hole formation?

Authors:  A J Singh; M M K Muqit; W H Woon
Journal:  Int Ophthalmol       Date:  2012-05-08       Impact factor: 2.031

6.  Macular cysts, holes and cavitations : 2006 Jules Gonin lecture of the Retina Research Foundation.

Authors:  A Gaudric
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-30       Impact factor: 3.117

7.  Comparison of full-thickness traumatic macular holes and idiopathic macular holes by optical coherence tomography.

Authors:  Jingjing Huang; Xing Liu; Ziqiang Wu; Srinivas Sadda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-24       Impact factor: 3.117

8.  Evolution of vitreomacular adhesion to acute vitreofoveal separation with special emphasis on a traction-induced foveal pathology. A prospective study of spectral-domain optical coherence tomography.

Authors:  George P Theodossiadis; Irini P Chatziralli; Theodoros N Sergentanis; Ioannis Datseris; Panagiotis G Theodossiadis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-10-15       Impact factor: 3.117

9.  [Ocriplasmin as a treatment option for symptomatic vitreomacular traction with and without macular hole. First clinical experiences].

Authors:  M Maier; S Abraham; C Frank; N Feucht; C P Lohmann
Journal:  Ophthalmologe       Date:  2015-12       Impact factor: 1.059

10.  [Importance of morphological and functional diagnostics of the vitreoretinal interface].

Authors:  W J Mayer; R G Schumann; A Kampik; C Haritoglou
Journal:  Ophthalmologe       Date:  2015-01       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.